Detalhe da pesquisa
1.
Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms?
Blood
; 2024 May 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38728380
2.
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party.
Am J Hematol
; 99(3): 360-369, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38165072
3.
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.
Am J Hematol
; 99(2): 203-215, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38009469
4.
Radiotherapy combination opportunities leveraging immunity for the next oncology practice.
CA Cancer J Clin
; 67(1): 65-85, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-27570942
5.
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis.
Lancet Oncol
; 24(6): 611-623, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37269842
6.
A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemia.
Blood
; 137(4): 524-532, 2021 01 28.
Artigo
Inglês
| MEDLINE | ID: mdl-32871585
7.
Fludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 98(4): 580-587, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36626592
8.
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 98(4): 628-638, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36606718
9.
Recurrences of ventricular tachycardia after stereotactic arrhythmia radioablation arise outside the treated volume: analysis of the Swiss cohort.
Europace
; 25(10)2023 Oct 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37695314
10.
Long-term results from a clinical study of xevinapant plus chemoradiotherapy in people with high-risk locally advanced squamous cell carcinoma of the head and neck: a plain language summary.
Future Oncol
; 19(26): 1769-1776, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37439181
11.
International assessment of interobserver reproducibility of flap delineation in head and neck carcinoma.
Acta Oncol
; 61(6): 672-679, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35139735
12.
Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design.
Future Oncol
; 18(14): 1669-1678, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35172587
13.
Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species.
Proc Natl Acad Sci U S A
; 116(22): 10943-10951, 2019 05 28.
Artigo
Inglês
| MEDLINE | ID: mdl-31097580
14.
Validation of Monte Carlo dose calculation algorithm for CyberKnife multileaf collimator.
J Appl Clin Med Phys
; 23(2): e13481, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34851007
15.
Commissioning and validation of RayStation treatment planning system for CyberKnife M6.
J Appl Clin Med Phys
; 23(8): e13732, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35856911
16.
[Place of stereotactic radiotherapy in oligoprogressive non-small cell lung cancer]. / Place de la radiothérapie stéréotaxique dans le cancer du poumon non à petites cellules en oligoprogression.
Rev Med Suisse
; 18(784): 1125-1133, 2022 Jun 01.
Artigo
Francês
| MEDLINE | ID: mdl-35647751
17.
[Management of brain metastases in 2022]. / Prise en charge des métastases cérébrales en 2022.
Rev Med Suisse
; 18(782): 976-983, 2022 May 18.
Artigo
Francês
| MEDLINE | ID: mdl-35583276
18.
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 22(4): 463-475, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33684370
19.
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Lancet Oncol
; 22(4): 450-462, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33794205
20.
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.
Lancet Oncol
; 22(5): 727-736, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33862002